Makes specialty ingredients: choline nutrients for animal feed, encapsulated nutrients for food, and performance/industrial chemicals.
Makes specialty ingredients: choline nutrients for animal feed, encapsulated nutrients for food, and performance/industrial chemicals.
Sells ingredients that customers blend into feed, foods and supplements, including choline protected to survive a cow's stomach, which helps dairy herd health. An ethylene oxide unit sells sterilisation gas and other specialty chemicals to healthcare and industrial users. Growth is helped by buying small niche ingredient companies.
Moat: narrow (IP / patents, process know-how, customer qualification). Encapsulation and specialty-chemical process know-how create qualification barriers for niche nutrient markets.
Headquarters: New Hampton, New York, US · Founded: 1967 · Employees: 1,352
Size Balchem (BCPC) is a United States Consumer Staples company (Food: Specialty/Candy) with a market value of $5.36B, the 1123rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $168.73 on 18 Nov 2026.
Performance Over six months the shares gained 4.7%, against +3.6% for the median peer and -2.2% for the United States market (cap-weighted) — 10th highest of 21 in its peer set.
Growth Revenue grew 9.4% over the last twelve months (peer median +6.5%); the operating margin is 21.5% (peer median 9.6%).
Valuation It trades at 29.9× forward earnings against a peer median of 17.6× (3rd most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.2 points above its cost of capital (9.2% WACC).
Short interest Short interest is 1.6% of the free float (30 Oct 2026).
Next results Next results expected around 19 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.11B | $1.04B | $954M | $922M | $942M |
| Revenue growth | — | +9% | +3% | -2% | — |
| Gross profit | $404M | $371M | $336M | $302M | $280M |
| EBITDA | $287M | $264M | $232M | $233M | $199M |
| Net income | $171M | $155M | $128M | $109M | $105M |
| Free cash flow | $178M | $173M | $146M | $146M | $88.2M |
| Capital expenditure | $45.8M | $43.5M | $35.7M | $37.9M | $50.3M |
| Total debt | $142M | $181M | $208M | $330M | $461M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Balchem BCPC | $5.36B | +5% | +9% | 22% | 29.9× | 14.3% |
| Archer Daniels Midland ADM | $32.3B | -13% | +1% | 3% | 11.7× | 7.9% |
| DSM-Firmenich DSFIR.AS | $27.5B | +47% | -45% | 8% | 28.6× | 23.7% |
| International Flavors & Fragrances IFF | $20.1B | +8% | -17% | 11% | 22.7× | 17.9% |
| Phibro Animal Health PAHC | $1.44B | +5% | +10% | 13% | 9.9× | -6.4% |
| Bluestar Adisseo 600299.SS | $3.70B | -34% | +15% | 13% | 11.3× | -9.4% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | BCPC | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -1.7% | +2.2% | 7th lowest of 21 |
| 6-month return | +4.7% | +3.6% | 10th highest of 21 |
| Distance from 52-week high | -9.4% | -18.7% | 4th highest of 21 |
| Revenue growth (TTM) | +9.4% | +6.5% | 9th highest of 21 |
| Operating margin | 21.5% | 9.6% | highest of 21 |
| Forward P/E | 29.9× | 17.6× | 3rd most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 14.3% | -1.5% | 2nd most demanding of 18 |
| Growth delivered (Del g) | +8.1% | +10.5% | 6th lowest of 18 |
| Hurdle (Req g minus delivered) | +6.3 pp | -8.6 pp | 2nd most demanding of 18 |
| ROIC minus cost of capital | +4.2 pp | +2.3 pp | 6th highest of 21 |
| EV / EBITDA | 18.9× | 10.0× | 2nd most expensive of 18 |
| Net debt / EBITDA | 0.3× | 1.0× | 5th least indebted of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Balchem BCPC | United States | $5.36B | +5% | +9% | 22% | 29.9× | 14.3% | +8.1% |
| Nissin Foods 2897.T | Japan | $5.38B | +10% | +7% | 6% | 17.3× | 6.6% | +9.3% |
| Yamazaki Baking 2212.T | Japan | $5.39B | +35% | +5% | 5% | 19.3× | -2.6% | +5.3% |
| Ingredion INGR | United States | $5.60B | -11% | -1% | 11% | 9.3× | -5.6% | +3.8% |
| Sensient Technologies SXT | United States | $5.00B | +3% | +10% | 15% | 24.6× | n/a | n/a |
| Angel Yeast 600298.SS | China | $5.00B | +5% | +15% | 11% | 19.7× | 4.3% | +13.4% |
| Aak AAK.ST | Sweden | $4.48B | -32% | -1% | 10% | 13.0× | -6.4% | +10.5% |
| Toyo Suisan Kaisha 2875.T | Japan | $6.81B | -1% | +7% | 17% | 14.8× | -4.3% | +9.5% |
| Anjoy Foods 603345.SS | China | $4.05B | -8% | +19% | 12% | 18.3× | -2.9% | +18.4% |
| Lamb Weston LW | United States | $7.20B | +25% | +3% | 10% | 15.7× | 3.9% | +12.5% |
| Campbell's CPB | United States | $7.27B | +22% | -5% | 11% | 14.4× | -2.5% | +2.8% |
| Vita Coco COCO | United States | $3.86B | -13% | +26% | 20% | 32.7× | 10.1% | +14.4% |
| Barry Callebaut BARN.SW | Switzerland | $8.04B | +4% | -18% | 5% | 23.3× | -7.1% | +11.1% |
| Darling Ingredients DAR | United States | $8.05B | -12% | +16% | 9% | 7.7× | 8.0% | +11.4% |
| Meiji 2269.T | Japan | $8.08B | +26% | +3% | 8% | 19.1× | n/a | n/a |
| Post POST | United States | $3.55B | -17% | +6% | 10% | 11.6× | -1.5% | +7.4% |
| Orion 271560.KS | South Korea | $3.52B | -20% | +12% | 17% | 10.3× | -15.6% | +8.4% |
| Ashland ASH | United States | $3.50B | +36% | +2% | 7% | 18.0× | 12.7% | -2.5% |
| Jinan Shengquan Group Share 605589.SS | China | $3.30B | -38% | +12% | 8% | 20.2× | n/a | n/a |
| Tate & Lyle TATE.L | United Kingdom | $3.27B | +11% | +2% | 8% | 15.8× | 13.2% | +10.6% |
| Freshpet FRPT | United States | $3.27B | +40% | +12% | 9% | 37.5× | 30.2% | +28.2% |